<DOC>
	<DOC>NCT01040052</DOC>
	<brief_summary>The objective of this study is to describe the safety of Adacel® vaccination in adults subjects in Vietnam. This study is conducted in accordance with Vietnamese regulation in support to Adacel® registration. Primary objective: To monitor the adverse effects of the vaccine ADACEL® from day 0 to day 30 after immunization.</brief_summary>
	<brief_title>A Study to Assess the Safety of Adacel® Vaccine</brief_title>
	<detailed_description>Participants will receive a single dose of Adacel® vaccine and will be followed closely during 30 minutes post-vaccination period; a home visit will be made daily during 7 days following vaccination in order to monitor safety. An additional visit will be conducted 30 days post-vaccination to collect safety information.</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Inclusion Criteria : Male or female (not pregnant) from 1845 years of age. Healthy, with no current illnesses. Have not been immunized against diphtheria, pertussis and tetanus in the past 5 years. Women of childbearing age will agree to use birth control during the study. In good health, as verified by the following criteria: Heart rate, blood pressure, temperature and health history. Able to understand and comply with requirements of the study. A voluntary consent form is required before participating in the study. Exclusion Criteria : History of allergy to any ingredient in the vaccine. A positive pregnancy test (for women of childbearing age) or women who are breastfeeding. Compromised immune system due to treatment of a progressive disease. Currently on oral or injected steroids, inhaled highdosage steroids or other immunodeficiency or toxic drugs. History of taking Immunoglobulin or other products during the 3 months prior to participating in the study. Received other vaccines during the 4 months prior to participating in the study. Has an acute or chronic condition that affects safety (including but not limited to: chronic liver disease, some kidney pathologies, progressive or unstabilized nerve disorders, diabetes and organ transplants). Experienced a severe adverse event after receiving ADACEL® vaccine. History of acute illness with temperatures over 37.5ºC during the week before receiving the vaccine. Human immunodeficiency virus (HIV) infection. History of alcohol or drug addiction during the past 5 years. Plans to travel outside of the study area between shots and visits. History of GuillainBarré syndrome.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Adacel®</keyword>
</DOC>